American Society of Gene Therapy Annual Meeting (2009-2013)

美国基因治疗学会年会（2009-2013）

• 批准号: 7749863
• 负责人: KENNETH CORNETTA
• 金额: $ 1万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7749863
• 关键词: American; Arts; Award; Cell Therapy; Cells; Development; Educational Grants; Ethical Issues; Ethicists; Fostering; Funding; Genes; Grant; Human; National Heart, Lung, and Blood Institute; Oral; Participant; Peer Review; Postdoctoral Fellow; Request for Proposals; Research; Research Personnel; Scientific Advances and Accomplishments; Scientist; Senior Scientist; Societies; Students; Technology; Thinking; Training; Travel; United States National Institutes of Health; Work; abstracting; base; gene therapy; innovation; insight; meetings; member; novel; posters; programs; public education; symposium

DESCRIPTION (provided by applicant): The American Society of Gene Therapy was founded in 1996 and is dedicated to the development of gene and cell therapies with a particular focus on professional and public education. Our Annual Meeting represents the major educational initiative of the Society and has been CME accredited for all of our prior 11 meetings. This R13 proposal requests support for travel grants and an educational program for trainees. Over 1/4 of our members are scientists in training working to develop clinically applicable gene-based technologies. Trainee participation in the Annual Meeting is fostered by an outstanding educational program, trainee travel awards, and recognition of outstanding scientific accomplishments through peer-reviewed trainee Excellence in Research Awards. Over the past decade, the ASGT has offered 470 travel grants and 63 Research Awards, with 20 travel grants per year for the past 5 years made possible by an R13 grant from the NHLBI. Educational opportunities for travel awardees include outstanding plenary speakers, state-of-the-art scientific symposia, and educational sessions that review current thinking on a variety of topics. In addition to leading scientists and clinicians, the program includes ethicists and representatives from the FDA, OBA, and NIH so young scientists may gain insight into the compliance and ethical issues related to human gene therapy. Trainees are active presenters in oral abstract and poster presentations and the top trainee abstracts are recognized at the Presidential Symposium. This proposal also requests partial support of a novel "Meet the Expert" program that allows trainees to interact with gene therapy leaders in a small group setting. The size of the ASGT meeting (approximately 2,000 participants) is ideally suited to expose young scientists to leaders in the field, yet provide opportunities for trainees to present their work at the premier meeting in the field of gene and cell therapy. Continued NIH support for the ASGT Annual Meeting will allow continued educational and professional advancement of trainees in the field of cell and gene therapy. (End of Abstract)

描述（由申请人提供）： 美国基因治疗协会成立于 1996 年，致力于基因和细胞疗法的开发，特别注重专业和公共教育。我们的年会代表了协会的主要教育举措，并且我们之前的 11 次会议均已获得 CME 认证。该 R13 提案要求支持旅费补助和学员教育计划。我们超过 1/4 的成员是正在接受培训的科学家，致力于开发临床适用的基因技术。优秀的教育计划、实习生旅行奖以及通过同行评审的实习生卓越研究奖对杰出科学成就的认可，促进了实习生参与年会。在过去的十年中，ASGT 提供了 470 项旅行补助金和 63 项研究奖，其中过去 5 年每年有 20 项旅行补助金是由 NHLBI 的 R13 补助金提供的。旅行获奖者的教育机会包括杰出的全体演讲者、最先进的科学研讨会以及回顾当前对各种主题的思考的教育会议。除了领先的科学家和临床医生外，该计划还包括来自 FDA、OBA 和 NIH 的伦理学家和代表，因此年轻科学家可以深入了解与人类基因治疗相关的合规性和伦理问题。学员是口头摘要和海报展示的活跃演讲者，顶级学员摘要将在主席研讨会上得到认可。该提案还要求部分支持一项新颖的“会见专家”计划，该计划允许学员在小组环境中与基因治疗领导者互动。 ASGT 会议的规模（约 2,000 名与会者）非常适合让年轻科学家接触该领域的领导者，同时为学员提供在基因和细胞治疗领域的重要会议上展示其工作的机会。 NIH 对 ASGT 年会的持续支持将使细胞和基因治疗领域的学员能够继续获得教育和专业进步。 （摘要完）